Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Pediatric PAH (Japan)
NCT01642407Phase 4Completed
- Sponsor
- Viatris
- Start
- Aug 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Viatris. Primary endpoints: Pulmonary Vascular Resistance Index at Week 16, Mean Pulmonary Artery Pressure at Week 16 and 3 more. Started Aug 2012; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01642407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642407.